Abstract:Rationale There are few data from systematic, double-blind clinical trials that have compared the effect of the typical and the atypical antipsychotics on serum prolactin (PRL) levels in patients with schizophrenia. Objectives The goal of this study was to compare the effect of risperidone and haloperidol on serum PRL and investigate the relationship between serum PRL levels and clinical response in patients with schizophrenia. Methods Seventy-eight inpatients with a diagnosis of schizophrenia (according to DSM-III-R) were randomly assigned to 12 weeks of treatment with 6 mg/day of risperidone or 20 mg/day of haloperidol after a 2-week washout period, using a randomized, double-blind design. Clinical efficacy was determined using the positive and negative syndrome scale (PANSS). Their serum PRL was assayed by means of radioimmunometric assay (RIA) between pre-treatment and post-treatment, and compared with 30 sex-matched and age-matched normal subjects. Results Both risperidone and haloperidol treatment significantly increased serum PRL levels in drug-free chronic schizophrenia patients (both P <0.001). Hyperprolactinemia induced by risperidone 6 mg/kg was comparable to levels produced by haloperidol 20 mg/day. Considering dose-adjusted serum PRL levels, risperidone treatment induced a significant elevation of PRL levels compared with haloperidol treatment at the haloperidol equivalent ( P <0.001). Change in PRL levels at pre-treatment and post-treatment were related to positive symptom improvement seen in the risperidone group ( r =0.51, P =0.016), but not in the haloperidol group ( P >0.05). Female patients showed both a higher baseline and post-treatment PRL level and a greater increase in PRL than men (all P <0.05). Conclusions Risperidone is associated with a robust effect on prolactin secretion in contrast to the conventional antipsychotic haloperidol. Prolactin monitoring during risperidone treatment should be performed.

Relationship of Risperidone in the Acute Phase of Schizophrenia with Plasma Homovanillic Acid

Efficacy and Safety of Long-Acting Risperidone on Early Onset Schizophrenia in Adolescent Patients

A double blinded multicenter clinical trial for evaluating the efficacy and safety of aripiprazole and risperidone in the treatment of schizophrenia

Effect of Risperidone on Serum Homocysteine Levels in First-Episode, Drug-Naïve Patients with Schizophrenia.

N-acetylaspartate reduction in the medial prefrontal cortex following 8 weeks of risperidone treatment in first-episode drug-naïve schizophrenia patients.

Effect of Risperidone Monotherapy on Dynamic Functional Connectivity of Insular Subdivisions in Treatment-Naive, First-Episode Schizophrenia

The Effects of Antipsychotics on Serum Prolactin in the First-Episode Schizophrenia Patients

Correlation between plasma homovanillic acid levels and the response to atypical antipsychotics in male patients with schizophrenia

Short-term Effects of Risperidone Monotherapy on Spontaneous Brain Activity in First-episode Treatment-naïve Schizophrenia Patients: A Longitudinal Fmri Study

Relationship between plasma risperidone concentrations and clinical features in chronic schizophrenic patients in China

Risperidone-induced Increase in Serum Prolactin is Correlated with Positive Symptom Improvement in Chronic Schizophrenia

Effect of resperidone treatment on serum levels of nonenzymatic antioxidant in drug-na?ve first-episode schizophrenic patients

Study on Efficacy and Safety of Risperidone in Treatment of Different Kinds of Schizophrenia

Effects of Anzapine and Risperidone on the Blood Lipid and Blood Rheology of Patients with Schizophrenia

Relationships between serum concentration and clinical effects in Han Chinese schizophrenia patients treated with risperidone

Effect of small dose of sodium valproate on the efficacy of risperidone and plasma concentration

Population Pharmacodynamic Models of Risperidone on PANSS Total Scores and Prolactin Levels in Schizophrenia

Prolactin Levels in Male Schizophrenic Patients Treated with Risperidone and Haloperidol: a Double-Blind and Randomized Study

Successful Treatment with Risperidone Increases 5-HT 3A Receptor Gene Expression in Patients with Paranoid Schizophrenia - Data from a Prospective Study.

Risperidone Versus Haloperidol in the Treatment of Acute Exacerbations of Chronic Inpatients with Schizophrenia: a Randomized Double-Blind Study

A Study on the Changes of Prolaction Levels of Female Patients with Schizophrenia after the Treatment of Aripiprazone, Ziprasidone and Risperidone